Clinical Trials Browser

Phase 2 × Breast Carcinoma In Situ × Bevacizumab × Clear all

NCT01641406 2012-07-16

NACprotocol

Phase 2 Unknown

Breast Carcinoma In Situ, Carcinoma, Lobular, Inflammatory Breast Neoplasms